Research areas

► government ethics and the regulation of health care (e.g., conflicts of interest, lobbying, revolving door, transparency)

► Food and Drug Administration (FDA)

► technologies (e.g., drugs, devices, AI, cybersecurity)

Metholodogical approach

► guided by economic and sociological theory

► quantitative (statistical / econometric) methods

► large administrative, survey, and other datasets


Recent Activity

>> New Publication <<

March 7, 2025

Unregulated large language models produce medical device-like output. npj Digital Medicine 2025; 4:148.

>> New Publication <<

September 20, 2024

Lessons from the Change Healthcare Ransomware Attack. JAMA Health Forum 2024; 5:e242764.

Public Comment

August 13, 2024

Comment on Optimizing the FDA’s Use of and Processes for Advisory Committees [Docket No. FDA-2024-N-1809]


Newsmax
America Right Now

March 1, 2025

Trump 2.0: Department of Health and Human Services [video @ 00:40]

Interview with Tom Basile

STAT News

November 24, 2024

Trump’s pick to run FDA is top exec of company that provides compounded weight-loss drugs (paywall) [PDF]

by John Wilkerson, Rachel Cohrs Zhang, and Katie Palmer